Transcatheter Heart Valve Replacement Market Size & Share 2020 to 2026

Report ID: GMI3170
   |
Published Date: January 2021
 | 
Report Format: PDF/Excel/Dashboard/Platform

Download Free PDF

Explore our licensing options:

Immediate Delivery Available

Transcatheter Heart Valve Replacement Market Size

Transcatheter Heart Valve Replacement Market size valued at over USD 6.2 billion in 2019 and is expected to witness 17.6% CAGR between 2020 and 2026.
 

Rise in incidences of valvular heart diseases across the globe along with increasing demand for less invasive procedures is propelling the industry growth. Growing geriatric population suffering from heart valve diseases is leading to increase in valve replacement surgeries. Moreover, increasing technological advancements in surgical procedures is augmenting the transcatheter heart valve replacement market demand. Furthermore, favorable reimbursement scenario and growing interest of manufacturers is fostering the market revenue.
 

Transcatheter Heart Valve Replacement Market

The COVID-19 pandemic has imposed burden on healthcare systems and intensive care unit (ICU) capacity that has led to the suspension of several procedures, including transcatheter aortic valve replacement (TAVR). The postponement of these procedures is associated with irreversible cardiac deterioration of patients or sudden cardiac death and is affecting patients suffering from severe aortic valve stenosis. Thus, the American College of Cardiology (ACC) and Society of Cardiac Angiography and Interventions (SCAI) have established guidelines regarding considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic addressing when to perform TAVR for severe symptomatic aortic stenosis. As a result, even with emergence of second wave of COVID-19, transcatheter heart valve industry will perform strongly in the coming duration.
 

 

Increasing prevalence of valvular disease in developing regions of Asia Pacific will drive the transcatheter heart valve replacement market growth. Aortic valvular stenosis or regurgitation caused by rheumatic heart disease or infective endocarditis is becoming prevalent at a rapid pace in developing countries of Asia Pacific. In addition, a major proportion of population in Asia Pacific suffering from rheumatic aortic stenosis comprises of young patients and is recommended to undergo transcatheter valve replacement. As a result, there is an increased demand for transcatheter heart valve replacement products in the region.
 

Transcatheter Heart Valve Replacement Market Analysis

Transcatheter mitral valve repair & replacement segment is poised to expand at 23.6% CAGR through 2026 owing to the increasing incidences of mitral regurgitation across the globe. Mitral regurgitation is the most prevalent abnormality worldwide and its prevalence is increasing in the geriatric population. According to a study by the National Center for Biotechnology Information (NCBI), approximately 1.3 million adults in the U.S. currently suffer from mitral regurgitation. Therefore, transcatheter mitral valve replacement (TMVR) has emerged as an alternative therapeutic option for the treatment of mitral regurgitation in patients with prohibitive or high surgical risk and is driving the demand for transcatheter mitral valves. Moreover, the growing incidences of ischemic functional secondary mitral regurgitation and degenerative primary mitral regurgitation is further uplifting the demand for transcatheter mitral valves.
 

Transapical approach segment is anticipated to register 18% growth rate during the forecast timeframe propelled by the antegrade approach and provision of easy wiring with excellent controllability. The transapical approach enables easier accessibility to the aortic valve with easier controllability. Therefore, this approach is widely used in transcatheter aortic valve implementation (TAVI) and transcatheter mitral valve replacement procedures. In addition, transapical approach is easier to perform, maintains proximity to the target and enables a controlled implantation.
 

Transcatheter Heart Valve Replacement Market By End-Use

Hospitals segment size in the transcatheter heart valve replacement market was more than USD 3,652 million in 2019 due to the reimbursement received by the hospitals for valve replacement procedures as these procedures are expensive. Moreover, presence of skilled surgeons in hospital setting and availability of technologically advanced equipment and tools utilized in heart valve replacement procedures is augmenting the number of people opting for transcatheter heart valve replacement in hospitals.
 

Aortic valvular heart disease segment revenue was around USD 4,818 million in 2019 on account of rising incidences of aortic valvular heart disease. Moreover, growing geriatric population is also contributing to the increasing prevalence of aortic valvular heart disease. This is because the people over the age of 70 years are prone to aortic stenosis. In addition, around 15% of the patients with 40 years or above age are prone to suffer from aortic stenosis due to bicuspid aortic valve. Aortic stenosis is the second most common valvular lesion in the U.S.
 

Global Transcatheter Heart Valve Replacement Market By Region

U.S. dominated the North America transcatheter heart valve replacement market and held largest revenue share of around 88% in 2019 attributed to the growing prevalence of heart valve disorders in the U.S. According to a published article, approximately, 5 million people in the U.S. are diagnosed with heart valve disorder every year. Therefore, more than 80,000 aortic valve replacement (AVR) procedures are performed each year in the country. As a result, the demand for transcatheter heart valves in the U.S. is consistent. Favorable reimbursement scenario by the Centers for Medicare & Mediclaim pertaining to transcatheter heart valve replacement procedures is additionally fueling the number of people undergoing valve replacement. Moreover, growing number of transcatheter aortic valve replacement centers (TAVR) centers in the U.S. is uplifting the adoption of AVR procedures in the country.
 

Germany transcatheter heart valve replacement market value in 2019 was over USD 383 million due to the improved healthcare infrastructure in the country and rising prevalence of aortic stenosis in geriatric population. According to a published report, more than 25,000 TAVR procedures are currently performed in Germany. The country has been leading in the clinical adoption of transcatheter aortic valve implantation (TAVI) and introduced TAVR routinely is some selected centers in 2006. Moreover, German Aortic Valve Registry, established in 2011, is engaged in providing data for reimbursement. Moreover, presence of highly skilled interdisciplinary team of heart specialists in the country is contributing to an increased number of transcatheter heart valve replacement procedures in the country.
 

Transcatheter Heart Valve Replacement Market Share

Some of the major players operating in the transcatheter heart valve replacement industry include

  • 4C Medical Technologies
  • Abbott
  • Boston Scientific
  • Edwards Lifesciences
  • HighLife Medical
  • JC Medical
  • LivaNova
  • Medtronic plc
  • Neovasc

These major market players are engaged in undertaking several strategic mergers, acquisitions, collaborations and partnerships in order to maintain a competitive edge over their peers. These players are also engaged in making investments that enables these players in capturing maximum revenue share.
 

Recent industry developments:

  • In April 2020, Abbott announced receiving CE Mark approval for TriClip Transcatheter Tricuspid Valve Repair System for use in Europe and other countries that consider CE Mark as a non-surgical treatment for people. The strategic move will assist the company in enhancing their product portfolio and expanding their geographical presence.
     
  • In September 2019, Medtronic plc announced the launch of Next-Generation Evolut PRO + TAVR System for treatment of symptomatic severe aortic stenosis patients. The strategic move assisted the company in enhancing their product portfolio and expanding their customer base.
     

The transcatheter heart valve replacement market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD and in terms of Units from 2015 to 2026, for the following segments:
 

Market, By Product

  • Transcatheter Aortic Valve Replacement
  • Transcatheter Mitral Valve Repair and Replacement
  • Transcatheter Pulmonary Valve Replacement

Market, By Surgical Approach

  • Transfemoral Approach
  • Transapical Approach
  • Others

Market, By Application

  • Aortic Valvular Heart Disease
    • Aortic Valve Stenosis
    • Aortic Valve Regurgitation
  • Mitral Valvular Heart Disease
    • Mitral Valve Stenosis
    • Mitral Valve Regurgitation
  • Pulmonary Valvular Heart Disease

Market, By End-Use

  • Hospitals
  • Cath labs

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel

 

Authors: Monali Tayade, Sampada Kulkarni
Transcatheter Heart Valve Replacement Market Scope
  • Transcatheter Heart Valve Replacement Market Size
  • Transcatheter Heart Valve Replacement Market Trends
  • Transcatheter Heart Valve Replacement Market Analysis
  • Transcatheter Heart Valve Replacement Market Share

Report Content

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates & working

1.3    Forecast calculations

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Transcatheter heart valve replacement industry 3600 synopsis, 2015 - 2026

2.1.1    Business trends

2.1.2    Product trends

2.1.3    Surgical approach trends

2.1.4    Application trends

2.1.5    End-use trends

2.1.6    Regional Trends

Chapter 3   Transcatheter Heart Valve Replacement Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2015 – 2026

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Rise in venture capital investments for transcatheter heart valve devices by major players in North America and Europe

3.3.1.2    Increasing technological advancements in surgical procedures for transcatheter heart valve replacement in Europe

3.3.1.3    Favourable reimbursement scenario in North America and Europe

3.3.1.4    Increasing prevalence of valvular heart disease in developing regions of Asia Pacific

3.3.1.5    Rising interest of manufacturers in emerging markets such as Middle East and Africa

3.3.2    Industry pitfalls & challenges

3.3.2.1    High cost and risk associated with the transcatheter heart valve replacement procedures in Asia Pacific

3.3.2.2    Stringent government regulations in developing regions

3.3.2.3    Insufficient healthcare infrastructures in Latin America

3.3.2.4    Lack of awareness regarding new minimally invasive surgical procedures and inadequate medical facilities in MEA

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By surgical approach

3.4.3    By application

3.4.4    By end-use

3.5    COVID-19 impact analysis

3.6    Regulatory landscape

3.6.1    U.S.

3.6.2    Europe

3.7    Porter’s analysis

3.8    Competitive landscape, 2019

3.8.1    Competitive matrix analysis, 2019

3.9    PESTEL analysis

Chapter 4   Transcatheter Heart Valve Replacement Market, By Product

4.1    Key segment trends

4.2    Transcatheter Aortic Valve Replacement

4.2.1    Market size, by region, 2015 – 2026 (USD Million)

4.2.2    Market size, by region, 2015 – 2026 (Units)

4.3    Transcatheter Mitral Valve Repair and Replacement

4.3.1    Market size, by region, 2015 – 2026 (USD Million)

4.3.2    Market size, by region, 2015 – 2026 (Units)

4.4    Transcatheter Pulmonary Valve Replacement

4.4.1    Market size, by region, 2015 – 2026 (USD Million)

4.4.2    Market size, by region, 2015 – 2026 (Units)

Chapter 5   Transcatheter Heart Valve Replacement Market, By Surgical Approach

5.1    Key segment trends

5.2    Transfemoral Approach

5.2.1    Market size, by region, 2015 – 2026 (USD Million)

5.3    Transapical Approach

5.3.1    Market size, by region, 2015 – 2026 (USD Million)

5.4    Others

5.4.1    Market size, by region, 2015 – 2026 (USD Million)

Chapter 6   Transcatheter Heart Valve Replacement Market, By Application

6.1    Key segment trends

6.2    Aortic Valvular Heart Disease

6.2.1    Market size, by region, 2015 – 2026 (USD Million)

6.2.2    Aortic Valve Stenosis

6.2.2.1    Market size, by region, 2015- 2016 (USD Million)

6.2.3    Aortic Valve Regurgitation

6.2.3.1    Market size, by region, 2015- 2016 (USD Million)

6.3    Mitral Valvular Heart Disease

6.3.1    Market size, by region, 2015 – 2026 (USD Million)

6.3.2    Mitral Valve Stenosis

6.3.2.1    Market size, by region, 2015- 2016 (USD Million)

6.3.3    Mitral Valve Regurgitation

6.3.3.1    Market size, by region, 2015- 2016 (USD Million)

6.4    Pulmonary Valvular Heart Disease

6.4.1    Market size, by region, 2015-2016 (USD Million)

Chapter 7   Transcatheter Heart Valve Replacement Market, By End-use

7.1    Key segment trends

7.2    Hospitals

7.2.1    Market size, by region, 2015 – 2026 (USD Million)

7.3    Cath Labs

7.3.1    Market size, by region, 2015 – 2026 (USD Million)

Chapter 8   Transcatheter Heart Valve Replacement Market, By Region

8.1    Key regional trends

8.2    North America

8.2.1    Market size, by country, 2015 -2026 (USD Million)

8.2.2    Market size, by country, 2015 -2026 (Units)

8.2.3    Market size, by product, 2015– 2026 (USD Million)

8.2.4    Market size, by product, 2015 – 2026 (Units)

8.2.5    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.2.6    Market size, by application, 2015-2026 (USD Million)

8.2.6.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.2.6.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.2.7    Market size, by end-use, 2015-2026 (USD Million)

8.2.8    U.S.

8.2.8.1    Market size, by product, 2015– 2026 (USD Million)

8.2.8.2    Market size, by product, 2015 – 2026 (Units)

8.2.8.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.2.8.4    Market size, by application, 2015-2026 (USD Million)

8.2.8.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.2.8.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.2.8.5    Market size, by end-use, 2015-2026 (USD Million)

8.2.9    Canada

8.2.9.1    Market size, by product, 2015– 2026 (USD Million)

8.2.9.2    Market size, by product, 2015 – 2026 (Units)

8.2.9.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.2.9.4    Market size, by application, 2015-2026 (USD Million)

8.2.9.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.2.9.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.2.9.5    Market size, by end-use, 2015-2026 (USD Million)

8.3    Europe

8.3.1    Market size, by country, 2015 -2026 (USD Million)

8.3.2    Market size, by country, 2015 -2026 (Units)

8.3.3    Market size, by product, 2015– 2026 (USD Million)

8.3.4    Market size, by product, 2015 – 2026 (Units)

8.3.5    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.3.6    Market size, by application, 2015-2026 (USD Million)

8.3.6.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.3.6.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.3.7    Market size, by end-use, 2015-2026 (USD Million)

8.3.8    Germany

8.3.8.1    Market size, by product, 2015– 2026 (USD Million)

8.3.8.2    Market size, by product, 2015 – 2026 (Units)

8.3.8.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.3.8.4    Market size, by application, 2015-2026 (USD Million)

8.3.8.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.3.8.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.3.8.5    Market size, by end-use, 2015-2026 (USD Million)

8.3.9    UK

8.3.9.1    Market size, by product, 2015– 2026 (USD Million)

8.3.9.2    Market size, by product, 2015 – 2026 (Units)

8.3.9.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.3.9.4    Market size, by application, 2015-2026 (USD Million)

8.3.9.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.3.9.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.3.9.5    Market size, by end-use, 2015-2026 (USD Million)

8.3.10    France

8.3.10.1    Market size, by product, 2015– 2026 (USD Million)

8.3.10.2    Market size, by product, 2015 – 2026 (Units)

8.3.10.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.3.10.4    Market size, by application, 2015-2026 (USD Million)

8.3.10.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.3.10.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.3.10.5    Market size, by end-use, 2015-2026 (USD Million)

8.3.11    Spain

8.3.11.1    Market size, by product, 2015– 2026 (USD Million)

8.3.11.2    Market size, by product, 2015 – 2026 (Units)

8.3.11.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.3.11.4    Market size, by application, 2015-2026 (USD Million)

8.3.11.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.3.11.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.3.11.5    Market size, by end-use, 2015-2026 (USD Million)

8.3.12    Italy

8.3.12.1    Market size, by product, 2015– 2026 (USD Million)

8.3.12.2    Market size, by product, 2015 – 2026 (Units)

8.3.12.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.3.12.4    Market size, by application, 2015-2026 (USD Million)

8.3.12.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.3.12.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.3.12.5    Market size, by end-use, 2015-2026 (USD Million)

8.4    Asia Pacific

8.4.1    Market size, by country, 2015 -2026 (USD Million)

8.4.2    Market size, by country, 2015 -2026 (Units)

8.4.3    Market size, by product, 2015– 2026 (USD Million)

8.4.4    Market size, by product, 2015 – 2026 (Units)

8.4.5    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.4.6    Market size, by application, 2015-2026 (USD Million)

8.4.6.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.4.6.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.4.7    Market size, by end-use, 2015-2026 (USD Million)

8.4.8    Japan

8.4.8.1    Market size, by product, 2015– 2026 (USD Million)

8.4.8.2    Market size, by product, 2015 – 2026 (Units)

8.4.8.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.4.8.4    Market size, by application, 2015-2026 (USD Million)

8.4.8.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.4.8.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.4.8.5    Market size, by end-use, 2015-2026 (USD Million)

8.4.9    China

8.4.9.1    Market size, by product, 2015– 2026 (USD Million)

8.4.9.2    Market size, by product, 2015 – 2026 (Units)

8.4.9.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.4.9.4    Market size, by application, 2015-2026 (USD Million)

8.4.9.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.4.9.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.4.9.5    Market size, by end-use, 2015-2026 (USD Million)

8.4.10    India

8.4.10.1    Market size, by product, 2015– 2026 (USD Million)

8.4.10.2    Market size, by product, 2015 – 2026 (Units)

8.4.10.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.4.10.4    Market size, by application, 2015-2026 (USD Million)

8.4.10.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.4.10.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.4.10.5    Market size, by end-use, 2015-2026 (USD Million)

8.4.11    Australia

8.4.11.1    Market size, by product, 2015– 2026 (USD Million)

8.4.11.2    Market size, by product, 2015 – 2026 (Units)

8.4.11.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.4.11.4    Market size, by application, 2015-2026 (USD Million)

8.4.11.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.4.11.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.4.11.5    Market size, by end-use, 2015-2026 (USD Million)

8.4.12    South Korea

8.4.12.1    Market size, by product, 2015– 2026 (USD Million)

8.4.12.2    Market size, by product, 2015 – 2026 (Units)

8.4.12.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.4.12.4    Market size, by application, 2015-2026 (USD Million)

8.4.12.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.4.12.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.4.12.5    Market size, by end-use, 2015-2026 (USD Million)

8.5    Latin America

8.5.1    Market size, by country, 2015 -2026 (USD Million)

8.5.2    Market size, by country, 2015 -2026 (Units)

8.5.3    Market size, by product, 2015– 2026 (USD Million)

8.5.4    Market size, by product, 2015 – 2026 (Units)

8.5.5    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.5.6    Market size, by application, 2015-2026 (USD Million)

8.5.6.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.5.6.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.5.7    Market size, by end-use, 2015-2026 (USD Million)

8.5.8    Brazil

8.5.8.1    Market size, by product, 2015– 2026 (USD Million)

8.5.8.2    Market size, by product, 2015 – 2026 (Units)

8.5.8.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.5.8.4    Market size, by application, 2015-2026 (USD Million)

8.5.8.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.5.8.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.5.8.5    Market size, by end-use, 2015-2026 (USD Million)

8.5.9    Mexico

8.5.9.1    Market size, by product, 2015– 2026 (USD Million)

8.5.9.2    Market size, by product, 2015 – 2026 (Units)

8.5.9.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.5.9.4    Market size, by application, 2015-2026 (USD Million)

8.5.9.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.5.9.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.5.9.5    Market size, by end-use, 2015-2026 (USD Million)

8.5.10    Argentina

8.5.10.1    Market size, by product, 2015– 2026 (USD Million)

8.5.10.2    Market size, by product, 2015 – 2026 (Units)

8.5.10.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.5.10.4    Market size, by application, 2015-2026 (USD Million)

8.5.10.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.5.10.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.5.10.5    Market size, by end-use, 2015-2026 (USD Million)

8.6    Middle East & Africa

8.6.1    Market size, by country, 2015 -2026 (USD Million)

8.6.2    Market size, by country, 2015 -2026 (Units)

8.6.3    Market size, by product, 2015– 2026 (USD Million)

8.6.4    Market size, by product, 2015 – 2026 (Units)

8.6.5    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.6.6    Market size, by application, 2015-2026 (USD Million)

8.6.6.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.6.6.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.6.7    Market size, by end-use, 2015-2026 (USD Million)

8.6.8    South Africa

8.6.8.1    Market size, by product, 2015– 2026 (USD Million)

8.6.8.2    Market size, by product, 2015 – 2026 (Units)

8.6.8.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.6.8.4    Market size, by application, 2015-2026 (USD Million)

8.6.8.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.6.8.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.6.8.5    Market size, by end-use, 2015-2026 (USD Million)

8.6.9    Saudi Arabia

8.6.9.1    Market size, by product, 2015– 2026 (USD Million)

8.6.9.2    Market size, by product, 2015 – 2026 (Units)

8.6.9.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.6.9.4    Market size, by application, 2015-2026 (USD Million)

8.6.9.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.6.9.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.6.9.5    Market size, by end-use, 2015-2026 (USD Million)

8.6.10    UAE

8.6.10.1    Market size, by product, 2015– 2026 (USD Million)

8.6.10.2    Market size, by product, 2015 – 2026 (Units)

8.6.10.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.6.10.4    Market size, by application, 2015-2026 (USD Million)

8.6.10.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.6.10.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.6.10.5    Market size, by end-use, 2015-2026 (USD Million)

8.6.11    Israel

8.6.11.1    Market size, by product, 2015– 2026 (USD Million)

8.6.11.2    Market size, by product, 2015 – 2026 (Units)

8.6.11.3    Market size, by surgical approach, 2015 – 2026 (USD Million)

8.6.11.4    Market size, by application, 2015-2026 (USD Million)

8.6.11.4.1    Market size, by aortic valvular heart disease, 2015-2026 (USD Million)

8.6.11.4.2    Market size, by mitral valvular heart disease, 2015-2026 (USD Million)

8.6.11.5    Market size, by end-use, 2015-2026 (USD Million)

Chapter 9   Company Profiles

Don't see your key competitors?

The companies listed in this report are a curated selection - not the full competitive universe.

Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.

Your competitive landscape may also include

Regional or domestic-only leaders not in the global top tier
Distributors and channel partners who control market access
Emerging disruptors, startups, or adjacent-industry entrants
Niche players focused on a specific application or end-use

Free customization - up to 20% of report value

Need specific data? Request customization and get the insights tailored to your exact requirements.

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected]

Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours below
country Flag
+1
img

Transcatheter Heart Valve Replacement Market

Get a free sample of this report
country Flag
+1
img
Get a free sample of this report Transcatheter Heart Valve Replacement Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Your personal details will remain secure and confidential

Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!